SCHEMBL20127465

SCHEMBL20127465

c1ccc2cc(-c3ccc(-c4c5ccccc5c(-c5c6ccccc6cc6c5oc5ccccc56)c5ccccc45)c4ccccc34)ccc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 3/20 0.42
ALOX5 P09917 2/20 0.39
GSTP1 P09211 1/20 0.36
CYP1B1 Q16678 2/20 0.36
CYP1A1 P04798 1/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C9 P11712 2/20 0.36
NPC1 O15118 1/20 0.36
CYP2C19 P33261 1/20 0.36
RAB9A P51151 1/20 0.36
AHR P35869 1/20 0.35
MIF P14174 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
PRKDC P78527 2/20 0.34
SOS1 Q07889 1/20 0.33
PIK3CD O00329 1/20 0.31
XRCC6 P12956 1/20 0.31
XRCC5 P13010 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127664 0.92 ALOX5 (0.41) GPR84ALOX5GSTP1CYP1B1CYP1A1
SCHEMBL10122599 0.91 GPR84 (0.40) GPR84ALOX5GSTP1CYP1B1CYP1A1
SCHEMBL10122559 0.89 GPR84 (0.40) GPR84ALOX5GSTP1CYP1B1CYP1A1
SCHEMBL20127460 0.88 GPR84 (0.39) GPR84ALOX5CYP1B1CYP1A1CYP1A2
SCHEMBL17944055 0.88 MEN1 (0.40) GPR84ALOX5CYP1B1NPC1RAB9A
SCHEMBL10122576 0.87 GPR84 (0.39) GPR84ALOX5CYP1B1CYP1A1CYP1A2
SCHEMBL20127433 0.87 ALOX5 (0.44) GPR84ALOX5GSTP1CYP1B1CYP1A1
SCHEMBL20416616 0.86 ALOX5 (0.38) GPR84ALOX5CYP1B1CYP1A1CYP1A2
SCHEMBL20131287 0.85 GPR84 (0.35) GPR84ALOX5CYP1B1CYP1A1CYP1A2
SCHEMBL10122379 0.85 ALOX5 (0.39) GPR84ALOX5GSTP1CYP1B1CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 GPR84 2389/4885ALOX5 4115/4885GSTP1 2505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.